top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Plant Natural Products for Human Health
Plant Natural Products for Human Health
Autore Zhang Hongjie
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (514 p.)
Soggetto non controllato PhGs
bitter orange
immunomodulator
A549 cells
bergapten
triptolide
BMP/Smad
phytochemicals
antioxidant enzymes
kumquat
MTT assay
HepaRG cells
human health
nanoparticles
dendritic cells
drug discovery
biofilm
catechin
antitubercular activity
Panax notoginseng saponins
animals
mouse-hair growth
A?
curcumin
WNT/?-catenin
copaiba
AD
Plasmodium parasites
traditional medicine
procyanidin A2
PET inhibition
rheumatoid arthritis
cannabinoid type 1 receptor
iridoids
inflammatory bowel disease
acute liver injury
human-hair-follicle dermal papilla cells
Neuroprotective
dihydromyricetin
AMPK
thromboembolism
ginseng
drug design and development
endoplasmic reticulum stress
mitogen-activated protein kinase
Nrf2
prenylated flavonoids
inflammation
preclinical studies
plants
dietary supplements
Glycyrrhiza uralensis
aspirin
Tripterygium wilfordii
P. eryngii
reperfusion
ethnopharmacology
glucans
innovation
hpatoprotection
hinokitiol
phytocannabinoid
antistaphylococcal activity
Shh/Gli
green tea
sesquiterpenoids
adjuvant-induced arthritis
yuzu
hepatotoxicity
p53/Bax
Keap1
nuclear factor-kappaB
oxidative stress
pharmacokinetic study
cinnamamides
toxicity
APAP
Astragali Radix
computational softwares
plant natural product
onion
anti-malaria activity
lipogenesis
bleeding time
diterpenoids
Penthorum chinense Pursh
myocardial hypertrophy
automation
adjuvant
grapefruit
melanoma cell
essential oil
sweet orange
Amadori rearrangement compounds
heme oxygenase
global health
calorie restriction
bergamot
liposomes
EGCG
celastrol
herb–drug interactions
cannabigerol
anti-inflammation
OH· free radical
molecular targets
gluconeogenesis
microbiome
SIRT1
fucoidan
heart
PC12 cells
acetaminophen
omics
time-kill assay
arthritis
lychee seed
bioinformatics
structure–activity relationship
precision medicine
orange petitgrain
immune modulation
antiproliferation
flavonoids
scoulerine
oleoresin
triterpenic acids
Cannabis sativa
NAFLD
biological activity
differentiation
oxygen consumption rate
mitochondrial bioenergetics
neroli
apoptosis
targeted delivery
platelet activation
protein kinase
heat-process
hepatic steatosis
hyperglycemia
natural products
lemon
genistein
neuroinflammation
astragaloside IV
cytoxicity
flavonoid
paracetamol
medicinal plants
insulin resistance
resveratrol
mandarin
garlic
TGF-?
morin hydrate
sirtuin 3
MMPs
gomisin N
lime
Ziziphus jujuba
antifungal activity
ischemia
migration
caspases
small molecules
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910346688103321
Zhang Hongjie  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Research of Pathogenesis and Novel Therapeutics in Arthritis
Research of Pathogenesis and Novel Therapeutics in Arthritis
Autore Tang Chih-Hsin
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (366 p.)
Soggetto non controllato receptor activator of nuclear factor ?B
infliximab
tripterine
triptolide
osteoblast
tumor necrosis factor-alpha
synovial cell
anti-arthritis
biosimilars
Epstein-Barr virus
cytokines
SOX9
parathyroid hormone
nitric oxide
rat
etanercept
angiogenesis
glycosylation
mitogen activated protein kinase
Th9 lymphocytes
rheumatoid arthritis
IL-6
clodronate
bone erosion
mesenchymal stem cells
collagen-induced arthritis
biological
gene expression
inflammatory arthritis
osteoarthritis
fraxinellone
nuclear factor kappa B
messenger RNA
inflammation
miRNA
disease-modifying
adipokines
WNT
glycoprotein 42
miR-199a-5p
proliferation
next-generation sequencing
collagen
osteoarthritis (OA)
experimental arthritis
bone morphogenetic protein
TNF-?
computational modeling
basic research
osteoclast
therapeutics
certolizumab pegol
chondrocytes
progenitor cells
adjuvant arthritis
adalimumab
triterpenoid
sclareol
TNF?
fibroblast growth factor 2
antibodies
osteoblasts
molecular pathology
Th17
immunology
obesity
visfatin
articular cartilage
autoimmune
biomarkers
celastrol
MAPK
disease pathways
IL1?
arthritis
bioinformatics
anticitrullinated peptide antibodies
drug delivery system
antagonists
shared epitope
pathology
SMA- and MAD-related protein
small-molecule inhibitor
transforming growth factor ?
mice
golimumab
spinal fusion
antirheumatic drug
early osteoarthritis
stem cell
rheumatoid factor
therapeutic antibody
bisphosphonate
osteoclastogenesis
interleukin
spondyloarthropathies
clinical translation
therapy
Traditional Chinese medicine
chemokines
structure
cell signaling
microRNA
ISBN 3-03897-066-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910346843303321
Tang Chih-Hsin  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui